FDA Regulation of Tobacco Products: What Can E-Cigarette Companies Expect From The Deeming Regulation?
Why Should You Attend: It is critical for manufacturers and importers of cigars, pipe tobacco, electronic cigarettes, dissolvable tobacco and other novel tobacco products to be prepared to comment on FDA’s new deeming rule as soon as it is promulgated, as well as to prepare to be subject to FDA’s regulatory requirements. This webinar will focus on FDA’s regulatory requirements of cigarettes and other tobacco products. The instructor will discuss Family Smoking Prevention and Tobacco Control Act including premarket review of new and modified tobacco products and FDA deeming regulation for novel tobacco products. Areas Covered in the Webinar: -Overview of the Family Smoking Prevention and Tobacco Control Act -Premarket Review of New and Modified Tobacco Products -Modified Risk Tobacco Products -Deeming Regulation: What E-Cigarettes and Other Tobacco Products Can Expect Who will benefit: -General Counsel and Management of tobacco companies, e-cigarette companies, etc. -Regulatory Compliance Associates and Managers -Medical professionals, public health and consumer advocates, and other individuals working in the smoking control/ harm reduction area -Regulatory affairs professionals and scientists who work in this area -Manufacturers and importers of e-cigarettes and other novel tobacco products -Suppliers to Tobacco Industry Instructor Profile: Azim Chowdhury, joined Keller and Heckman in 2010 and practices in the area of food and drug law. Mr. Chowdhury advises domestic and foreign corporations in matters of FDA and international regulatory compliance. In particular, he assists corporations in establishing clearances for food and drug additives in the U.S., Canada, and European Union, with an emphasis on indirect additives used in food-contact materials. He has also developed expertise in tobacco product regulation and has experience representing tobacco manufacturers and suppliers, including electronic cigarette companies, in FDA regulatory matters. He is also a frequent contributor to the Food and Drug Law Institute’s (FDLI) Update magazine, currently serves on the Editorial Advisory Board of the Food and Drug Law Journal, and edited and co-authored FDLI’s first tobacco-exclusive publication, Tobacco Regulation and Compliance: An Essential Resource. For Registration:http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=703107?channel=limesfinder
